Expert consensus of management of adverse drug reactions with anaplastic lymphoma kinase tyrosine kinase inhibitors.
Zhou F, Yang Y, Zhang L, Cheng Y, Han B, Lu Y, Wang C, Wang Z, Yang N, Fan Y, Wang L, Ma Z, Zhang L, Yao Y, Zhao J, Dong X, Zhu B, Zhou C.
Zhou F, et al.
ESMO Open. 2023 Jun;8(3):101560. doi: 10.1016/j.esmoop.2023.101560. Epub 2023 May 23.
ESMO Open. 2023.
PMID: 37230029
Free PMC article.
Review.